Gwen A Melincoff

CIK 1614890 · last filed 2026-07-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.94M

Companies

7

Total Filings

32

Lifetime Open-Market Net

$15.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GANX Director $1.72 $0 5 2026-07-17
PLX Director 7,500 $2.25 $16.9K $0 4 2025-09-04
COLL Director 52,468 $36.31 $1.91M $0 5 2024-05-16
SOLENO THERAPEUTICS INC (SLNO) Delisted Director 666 $53.01 $35.3K $15.4K 7 2023-05-26
SOLENO THERAPEUTICS INC (SLNOW) Delisted Director $0 2 2019-06-12
ESPR Director 6,960 $3.18 $22.1K $0 3 2019-04-29
Tobira Therapeutics, Inc. (TBRA) Delisted Director $0 3 2016-01-14

Recent Filings · Page 4 of 4

32 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-07-13 Tobira Therapeutics, Inc. (TBRA) Delisted Grant (A) $0 EDGAR
2015-05-06 Tobira Therapeutics, Inc. (TBRA) Delisted Grant (A) $0 EDGAR
Showing 3132 of 32
Page 4 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.